Search results
H. Michael Shepard (born 1949) is an American cancer researcher who was awarded the 2007 Harvard Medical School Warren Alpert Foundation Prize and the 2019 Lasker Clinical research award, which he shared with Dennis Slamon and Axel Ullrich for their development of Herceptin
Mar 15, 2024 · In this World View, H. Michael Shepard describes his personal story behind the discovery of trastuzumab, 25 years since its FDA approval for HER2-overexpressing breast cancers.
Nov 30, 2021 · Dr. Michael Shepard is the President and CSO of Enosi Life Sciences, a company developing biologics for autoimmune and cancer diseases. He won the 2019 Lasker-DeBakey Award for inventing Herceptin, a targeted antibody therapy for breast cancer.
H. Michael Shepard is one of the three scientists who invented Herceptin, the first monoclonal antibody that blocks a cancer-causing protein and treats breast cancer. He received the 2019 Lasker~DeBakey Clinical Medical Research Award with Dennis J. Slamon and Axel Ullrich.
Dr. Michael Shepard is an orthopaedic surgeon who specializes in the treatment of knee, elbow and shoulder injuries in Orange and Irvine.
Sep 24, 2019 · Dr. H. Michael Shepard and his team have identified a critical breast cancer biomarker and developed the drug Herceptin, which can treat more than just breast cancer.
Michael F. Shepard, M.D. Dr Shepard is a board certified Orthopaedic Surgeon who is subspecialty trained in sports medicine with special emphasis on the care of the overhead athlete and knee ligament reconstruction.
